Showing 2031-2040 of 5771 results for "".
- Johnson & Johnson Vision Presents New Myopia Progression and Contact Lens Findings at American Academy of Optometry Annual Meetinghttps://modernod.com/news/johnson-johnson-vision-presents-new-myopia-progression-and-contact-lens-findings-at-american-academy-of-optometry-annual-meeting/2478387/Johnson & Johnson Vision announced clinical data from the latest in myopia research at the American Academy of Optometry’s virtual annual meeting (Academy 2020). Investigators will also reveal findings that demonstrate how Acuvue Oasys 1-Day with Hydraluxe Technology Contact Lenses redu
- Bausch + Lomb Announces New Scientific and Clinical Analyses to be Presented at American Academy of Optometry Annual Meetinghttps://modernod.com/news/bausch-lomb-announces-new-scientific-and-clinical-analyses-to-be-presented-at-american-academy-of-optometry-annual-meeting/2478386/Bausch + Lomb announced that three poster presentations will feature the company’s new silicone hydrogel (SiHy) daily disposable contact lens, Bausch + Lomb Infuse, during the virtual American Academy of Optometry (AAO) annual meeting (Oct. 7-22, 2020). “Over the past two decades, we have
- Allergan Announces REFRESH Concierge Program for ECPshttps://modernod.com/news/allergan-announces-refresh-concierge-program-for-ecps/2478382/Allergan announced the launch of its REFRESH Concierge service. The REFRESH Concierge is a full-service, dedicated remote support team providing eye care professionals with: Patient coupons Product education Help creating a REFRESH Direct eCommerce online sto
- Dell, HP, Lenovo and Acer to Announce New Eyesafe Products at the Blue Light Summit 2020https://modernod.com/news/dell-hp-lenovo-and-acer-to-announce-new-eyesafe-products-at-the-blue-light-summit-2020/2478378/Eyesafe, UnitedHealthcare Vision, and TÜV Rheinland Group announced the dates and registration details as well as the initial lineup of companies and thought leaders participating in the Blue Light Summit 2020. This year’s event will be held on Oct. 15, 2020. D
- American Academy of Optometry Foundation Announces the 2020-2021 Allergan Foundation Research Grant Recipientshttps://modernod.com/news/american-academy-of-optometry-foundation-announces-the-2020-2021-allergan-foundation-research-grant-recipients/2478375/The American Academy of Optometry Foundation (AAOF), in partnership with the Allergan Foundation, has announced two grant recipients this year in the areas of the anterior segment and glaucoma. The recipient of the Allergan Foundation Grant in the area of the anterior segment is Suzanne MJ
- Samsung Bioepis and Biogen Announce EMA Filing Acceptance of Proposed Lucentis Biosimilarhttps://modernod.com/news/samsung-bioepis-and-biogen-announce-ema-filing-acceptance-of-proposed-lucentis-biosimilar/2478376/Samsung Bioepis and Biogen announced that the European Medicines Agency (EMA) has accepted for review its Marketing Authorization Application for SB11, a proposed biosimilar referencing Lucentis (ranibizumab). Ranibizumab is an anti-VEGF (vascular endothelial growth factor) for retinal vascular d
- New Survey Finds Most People Say They Know the Importance of an Annual Eye Exam But They’re Not Getting Onehttps://modernod.com/news/new-survey-finds-most-people-say-they-know-the-importance-of-an-annual-eye-exam-but-theyre-not-getting-one/2478373/Johnson & Johnson Vision announced findings from a comprehensive, large-scale global eye health survey in advance of World Sight Day on October 8. The survey reveals both a disconnect in patient views towards the importance of eye health and how they prioritize i
- TearSolutions Announces Results From Primary Sjögren’s Syndrome Trial and Appoints Anil Asrani President and CEOhttps://modernod.com/news/tearsolutions-announces-results-from-primary-sjocc88grens-syndrome-trial-and-appoints-anil-asrani-president-and-ceo/2478369/TearSolutions announced the completion and preliminary outcomes of a phase 1/2 trial of Lacripep in Primary Sjögren’s Syndrome (PSS) patients. The trial was designed to test proof of concept and optimize the design f
- Oculis Announces Presentation of Positive Results From Phase 2 Trial of OCS-01 in Patients With Diabetic Macular Edema (DME)https://modernod.com/news/oculis-announces-presentation-of-positive-results-from-phase-2-trial-of-ocs-01-in-patients-with-diabetic-macular-edema-dme/2478362/Oculis announced that the positive results from the successful phase 2 (DX-211) clinical trial investigating OCS-01 for the treatment of diabetic macular edema (DME) were presented at Euretina 2020 Virtual during the Late Breaking & Reviews session on October 3. OCS-01 is a novel, high
- ProQR Announces Virtual Presentations at Euretina and AAOpthttps://modernod.com/news/proqr-announces-virtual-presentations-at-euretina-and-aaopt/2478348/ProQR Therapeutics announced virtual presentations at the Ophthalmology Futures Retina Forum, European Society of Retina Specialists (Euretina) congress and the Annual Meeting of the American Academy of Optometry (AAOpt). ProQR’s presentation at Ophthalmology Futures Retina Forum</